Isoniazid Proliposome Powders for Inhalation
Author Information
Author(s): Rojanarat Wipaporn, Changsan Narumon, Tawithong Ekawat, Pinsuwan Sirirat, Chan Hak-Kim, Srichana Teerapol
Primary Institution: Prince of Songkla University
Hypothesis
The study aims to develop proliposome powders containing isoniazid in a dry powder aerosol form.
Conclusion
INH-proliposome powders are potential candidates for an alternative tuberculosis treatment, showing better efficacy against M. bovis-infected alveolar macrophages than free INH.
Supporting Evidence
- INH-proliposome formulations showed mass median aerodynamic diameters suitable for pulmonary delivery.
- Proliposomes were nontoxic to respiratory-associated cells and did not provoke inflammatory responses.
- INH-proliposomes exhibited significantly higher efficacy against M. bovis-infected alveolar macrophages compared to free INH.
Takeaway
Researchers created a new type of medicine that can be inhaled to treat tuberculosis, and it works better than the regular version of the medicine.
Methodology
Proliposome powders were prepared using a spray drying method, and their properties were evaluated through various physicochemical tests and in vitro studies.
Limitations
The study did not explore long-term stability or clinical efficacy in humans.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website